Alexis Battle is an Associate Professor at Johns Hopkins University with appointments in Biomedical Engineering , Computer Science , and Genetic Medicine (secondary). She directs the Malone Center for Engineering in Healthcare and serves as Deputy Director of the Data Science and AI Institute . Educated at Stanford University (PhD in Computer Science, 2013), Battle transitioned to academia after leadership roles at Google. Research Focus: Battle’s work bridges genomics and machine learning , emphasizing the impact of genetic variation on human health. Her lab develops tools like Watershed to predict functional effects of rare variants, aiming to enhance rare disease diagnosis. Key themes include non-coding DNA analysis , personalized genomics , and systems biology , with applications in cardiovascular disease and neurodegenerative disorders . Publications & Awards: Over 60 peer-reviewed articles in journals like Nature , Science , and Genome Biology , with recent emphasis on single-cell transcriptomics , multiomics integration , and telomere biology . Recipient of the President’s Frontier Award (2022), Microsoft Investigator Fellowship (2019), and Searle Scholar (2016). Scientific Awards: 2022 President’s Frontier Award 2019 Microsoft Investigator Fellowship 2019 Johns Hopkins Discovery Award 2017 Johns Hopkins Catalyst Award 2016 Searle Scholar Advising & Funding: Mentors 11 PhD students, 3 undergraduates, and postdoctoral fellows. Her research is funded by NIH, Searle Scholars, and institutional grants. The Battle Lab collaborates on projects like the GTEx Consortium , focusing on gene regulation and clinical genomics .
Gail E. Kaiser is a Professor of Computer Science and the Director of the Programming Systems Laboratory (PSL) in the Computer Science Department at Columbia University. She has been with Columbia University since 1985, becoming a full Professor in 1998. Prof. Kaiser's research spans software engineering, program analysis, software testing, and software security, with recent focus on addressing challenges in AI/ML systems testing and security. Prof. Kaiser received her PhD in Computer Science from Carnegie Mellon University in 1985 and her ScB in Computer Science and Engineering from MIT in 1979. Her dissertation at CMU was titled "Semantics for Structure Editing Environments" under advisor Nico Habermann, and at MIT she completed "Automatic Extension of an Augmented Transition Network Grammar for Morse Code Conversations" under advisor Al Vezza. Prof. Kaiser's research interests primarily focus on software engineering following a systems building approach, with recent emphasis on static and dynamic program analysis techniques to improve software reliability and security. Since 2005, she has investigated testing "non-testable" programs, particularly in machine learning, data mining, and scientific computing applications where traditional testing oracles are insufficient. She has developed novel techniques and tools for detecting bugs and verifying repairs in complex systems. Concurrently, she has worked on collaboration environments for computational scientists, creating knowledge sharing and domain-aware environments to support scientific workflows. Prof. Kaiser's recent publications demonstrate a strong focus on the intersection of software engineering and artificial intelligence. Her work addresses critical challenges in testing AI systems, code understanding through deep learning, vulnerability detection, and educational tools for computational thinking. There's a clear evolution from traditional software engineering topics toward AI/ML applications, with particular emphasis on metamorphic testing for non-testable systems, code similarity analysis, and educational applications. Prof. Kaiser has received numerous prestigious awards throughout her career: Distinguished Journal Award (10 Years) from 18th IEEE International Conference on Software Testing, Verification and Validation (ICST), April 2025 Best Research Paper Award at 24th IEEE International Conference on Source Code Analysis & Manipulation (SCAM), October 2024 Distinguished Reviewer Awards for ASE 2024 and FSE 2024 ACM SIGSOFT Distinguished Paper Award for "CONCORD: Clone-aware Contrastive Learning for Source Code", July 2023 Best Student Paper Award at ICCE 2021 Multiple ACM SIGSOFT Distinguished Paper Awards dating back to 2014 Presidential Young Investigator in Software Engineering and Software Systems from NSF (1988-1993) Prof. Kaiser has chaired Columbia's doctoral program since 1997 and served on editorial boards including IEEE Internet Computing and as a founding associate editor of ACM Transactions on Software Engineering and Methodology. Her lab has been continuously funded by major agencies including NSF, NIH, DARPA, ONR, NASA, and numerous companies. Current grants include significant NSF funding for secure containers architecture, learning semantics of code for software assurance, and finding semantic security bugs. As Director of the Programming Systems Laboratory (PSL), Prof. Kaiser leads research in software systems, program analysis, and software testing. The lab has developed numerous tools and techniques for software reliability and security, with recent focus on challenges in AI/ML systems. Her work bridges theoretical foundations with practical applications, often resulting in deployable tools that address real-world software engineering challenges.
Thomas Michaels is an Assistant Professor at the Department of Biology, ETH Zürich, leading the Michaels Group . His research focuses on theoretical models of biomolecular condensates and protein aggregation in biological systems. Research Themes : Protein aggregation, liquid-liquid phase separation, membrane biophysics, and the role of condensates in neurodegenerative diseases like Alzheimer’s and Parkinson’s. Collaborative Approach : Integrates theoretical physics, control theory, and computational biology with experimental validation to design therapeutic strategies. Recent Publications highlight his work on amyloid formation mechanisms, lipid interactions, and phase-separated compartments as biochemical reactors. His group trains PhD students in systems biology and biocondensate physics.
Rebecca Schulman is an Associate Professor in the Department of Chemical and Biomolecular Engineering at the Whiting School of Engineering, Johns Hopkins University. She holds secondary appointments in Chemistry and Computer Science and is affiliated with multiple interdisciplinary institutes, including the Institute for NanoBioTechnology, the Hopkins Extreme Materials Institute, the Chemistry-Biology Interface Program, the Center for Cell Dynamics, and the Laboratory for Computational Sensing and Robotics. She currently co-directs the Passport to Future Technology Leadership program for PhD students. Research Interests: Schulman's research lies at the intersection of DNA nanotechnology, synthetic biology, and smart materials. Her group develops intelligent, adaptive biomolecular materials and nanostructures by integrating concepts from materials science, biochemistry, circuit design, and soft matter physics. The team focuses on engineering dynamic self-assembly processes using DNA to create reconfigurable materials, molecular circuits, and autonomous soft micro-robots. Key themes include self-healing nanostructures, feedback-regulated crystallization, programmable hydrogels, and synthetic genetic networks for materials control. Publication Trends: Her recent publications demonstrate a consistent focus on using DNA-based chemical reaction networks to program spatial and temporal behavior in materials. The work spans from fundamental mechanisms like catalytic polymerization and crystal growth regulation to applications in soft robotics, self-wiring circuits, and synthetic pattern formation. The research is highly interdisciplinary, combining synthetic biology with materials engineering to achieve life-like functionalities in non-living systems. Scientific Awards: AIMBE Fellowship Award Vannevar Bush Faculty Fellowship Award Hartwell Individual Biomolecular Research Award President’s Early Career Award in Science and Engineering (PECASE) DARPA Young Faculty Award DARPA Directors Fellowship NSF CAREER Award Turing Scholar Award DOE Early Career Award Advising and Grants: Schulman mentors graduate students and leads a vibrant research group focused on next-generation biomolecular engineering. Her work is supported by major federal grants, including the NSF CAREER, DOE Early Career, DARPA, and the Vannevar Bush Fellowship—a prestigious Department of Defense award for basic research. She is actively involved in training future leaders through programs like the Passport to Future Technology Leadership. Labs and Teams: The Schulman Lab at Johns Hopkins is a multidisciplinary team working on DNA-powered materials and molecular programming. The lab is embedded within several collaborative centers, enabling strong cross-departmental and cross-institutional research. Their work combines experimental biochemistry with theoretical modeling to design and implement complex molecular systems.
Dieter Braun is a Professor in the Faculty of Physics at Ludwig Maximilian University of Munich (LMU), leading the Functional NanoSystems research group. He serves as speaker of the CRC 235 Emergence of Life and coordinates the Molecular Origins component of the Origins Cluster. Dr. Braun holds an ERC Synergy Grant (starting April 2025), leads the CRC 392 Molecular Evolution (starting April 2024), and is a Fellow in the Max Planck School Matter to Life (since October 2023). His research focuses on understanding the physical mechanisms that could have led to the emergence of Darwinian evolution from prebiotic molecules on early Earth. Braun's laboratory investigates non-equilibrium settings, particularly asymmetrically heated open cracks in rocks, which create intricate wet-dry cycles, temperature gradients, and fluidic effects that could drive molecular evolution. His work bridges physics, chemistry, and biology to explore how dead molecules might combine through physical forces into autonomous mechanisms of evolution. Analysis of Braun's recent publications reveals a strong focus on thermal gradients and non-equilibrium physics in prebiotic environments. His research demonstrates how heat flows can concentrate molecules, drive polymerization, create pH gradients, and enable non-enzymatic replication of nucleic acids. The publications span high-impact journals including Nature, Nature Physics, and Nature Chemistry, showing interdisciplinary work connecting physics, chemistry, geology, and biology in the context of life's origins. Klung-Wilhelmy Weberbank Price (2011) Technology Transfer Price of the DPG (with LMU and NanoTemper) Deutscher Innovationspreis (2012) Step Award (2012) Dr. Braun has successfully mentored numerous PhD students, including Stefan Duhr and Philipp Baaske who founded the award-winning startup NanoTemper Technologies. His research is supported by multiple prestigious grants including ERC Starting, Advanced, and Synergy Grants, as well as funding from the Simons Collaboration on the Origins of Life. His laboratory collaborates extensively with other researchers across disciplines and institutions, particularly with Hannes Mutschler in the new ERC Synergy project. The Braun laboratory operates within the CRC 235 Emergence of Life and the Origins Cluster at LMU Munich, with strong connections to the Max Planck Society through the Max Planck School Matter to Life. The research group maintains active collaborations with geochemists, biophysicists, and molecular biologists to create comprehensive experimental models of prebiotic environments.
George Perry is a Professor of Anthropology at Pennsylvania State University, with research intersections in Biology, Evolutionary Medicine, and Genomics. He is affiliated with the Huck Institutes' Center for Infectious Disease Dynamics, Ecology, Molecular Cellular and Integrative Biosciences, and Bioinformatics and Genomics programs. Perry directs the Anthropological Genomics Lab , focusing on paleogenomics and evolutionary adaptation. Research areas: anthropological genomics, parasite evolution, human body size transitions, and evolutionary medicine Key collaborations: international teams in Madagascar, Europe, and Africa Leadership: Bioinformatics and Genomics Chair (2019–2023) His 2025–2022 publications span evolutionary responses to invasive species, human migration health impacts, chemosensory gene adaptation, and primate genomic diversity. Notable methodological contributions include ancient DNA recovery and comparative paleogenomics. Perry advises graduate students like Vanessa Garcia and Annette Mercedes, with grants including NIH support for Cuban health disparity studies. Scientific leadership includes tenure-line promotions (2023) and NASA Space Grant collaborations.
Jens S. Andersen is a Professor in the Department of Biochemistry and Molecular Biology at the University of Southern Denmark, where he leads research in Biomedical Mass Spectrometry and Systems Biology. His work is centered on the development and application of quantitative mass spectrometry and microscopy-based proteomics to study human cell biology, particularly the structure and function of organelles such as centrosomes, cilia, autophagosomes, and mitochondria. His research focuses on determining the protein composition and dynamic properties of cellular organelles, the roles of specific protein groups, and their contributions to biological processes and diseases. He investigates cell signaling mediated by post-translational modifications, especially within the DNA damage response, autophagy, and immune systems. His lab, the Jens S. Andersen Lab, is part of the Research Section of Biomedical Mass Spectrometry. The analysis of his recent publications reveals a strong interdisciplinary trend combining proteomics, structural biology, and cell signaling. His work spans cilia biology, RNA metabolism, DNA repair, and cancer mechanisms, with frequent use of advanced techniques like mass spectrometry, CRISPR, and live-cell imaging. The integration of systems biology approaches is evident across his research outputs. Professor, Department of Biochemistry and Molecular Biology, University of Southern Denmark Head of Research, Biomedical Mass Spectrometry and Systems Biology Principal Investigator, Jens S. Andersen Lab ORCID: 0000-0002-6091-140X While no specific scientific awards are mentioned in the provided texts, his extensive publication record in high-impact journals such as Science , Nature Communications , Molecular Cell , and EMBO Journal reflects significant scholarly contributions. He has supervised research projects and collaborated widely across Europe, though specific names of students are not listed. His research is supported by multiple ongoing projects, reflecting sustained funding and academic leadership. The Jens S. Andersen Lab operates at the intersection of proteomics and cell biology, contributing to fundamental understanding of organelle dynamics and disease mechanisms. The lab's work is highly collaborative, involving partnerships with groups in structural biology, RNA research, and cancer biology.
Peter A. Jones is President and Chief Scientific Officer at the Van Andel Institute (VAI) in Grand Rapids, Michigan, where he leads the Department of Epigenetics. He previously served as Director of the USC Norris Comprehensive Cancer Center from 1993 to 2011 and has been a central figure in advancing epigenetics research, particularly in cancer. His laboratory investigates DNA methylation, chromatin dynamics, and epigenetic therapies. Research Interests: Dr. Jones's work centers on epigenetic mechanisms in cancer, including DNA methylation, histone modifications, nucleosome positioning, and the therapeutic potential of epigenetic drugs. His research has pioneered the use of DNA methylation inhibitors like 5-azacytidine and explored viral mimicry as a mechanism for immune activation in cancer. He also studies transposable elements and their role in gene regulation and immune response. Publication Trends: His recent publications (2021–2024) reveal a strong focus on the interplay between epigenetics and immunotherapy, particularly how DNA methyltransferase inhibitors (DNMTi) induce viral mimicry, enhance immune recognition, and improve responses to checkpoint blockade. Studies span hematological malignancies, solid tumors, and T cell biology, with frequent collaboration with Stephen Baylin and others. Scientific Awards: Member, National Academy of Sciences Member, National Academy of Medicine Fellow, AACR Academy Fellow, AAAS Fellow, American Academy of Arts and Sciences Kirk A. Landon Award for Basic Cancer Research (2009) Medal of Honor, American Cancer Society (2011) Outstanding Investigator Grant, NCI Harvey Prize (2024) Advising and Grants: Dr. Jones mentors multiple postdoctoral fellows, graduate students, and research scientists. His lab is supported by major grants, including the VAI-SU2C Epigenetics Dream Team, which has launched 15 clinical trials. He has received sustained funding from the National Cancer Institute and collaborates with institutions worldwide to advance epigenetic therapies. Labs and Teams: He leads the Peter Jones Laboratory at VAI, a multidisciplinary team investigating epigenetic regulation in cancer. The lab includes computational biologists, clinical researchers, and molecular biologists, working on both basic mechanisms and translational applications. The team is part of larger collaborative initiatives such as the VAI-SU2C Epigenetics Dream Team and the International Linked Clinical Trials Program.
Henry D. Pfister is the Addy Family Professor of Electrical and Computer Engineering at Duke University, with a secondary appointment in Mathematics. He holds affiliations with the Pratt School of Engineering and the Duke Quantum Center. His research focuses on information theory, error-correcting codes, quantum computing, and machine learning applications in communications. Pfister earned his Ph.D. from UC San Diego and has held prior roles at Texas A&M University, École Polytechnique Fédérale de Lausanne, and Qualcomm. Education: Ph.D. in Electrical Engineering, UC San Diego (2003); M.S. degrees in Public Policy and Environmental Management from Duke University; J.D. and additional degrees from UNC Chapel Hill. Research interests include Reed-Muller codes, quantum error correction, neural decoders for DNA storage, and capacity-achieving coding schemes. Recent work highlights include proving Reed-Muller codes achieve capacity on binary-erasure channels and developing quantum-enhanced classical communication protocols. Publications span topics like polar codes for quantum channels, belief-propagation algorithms, and neural network-based decoding. Notable grants include NSF funding for DNA storage coding and quantum simulation projects. Pfister has advised over 20 graduate students and is a recipient of the STOC Best Paper Award and NSF CAREER Award.
Ross Thyer is an Assistant Professor in the Department of Chemical and Biomolecular Engineering at Rice University. He holds a BSc (Hons) from the University of Western Australia and a PhD from the Harry Perkins Institute of Medical Research under Drs. Rackham and Filipovska. His postdoctoral training at the University of Texas at Austin with Prof. Andrew Ellington focused on engineered biosynthesis pathways and non-canonical amino acids. He co-founded GRO Biosciences, a Boston-based biotech startup, and leads the Thyer Lab at Rice. His research bridges synthetic biology, protein engineering, and molecular programming to address global challenges. Key areas include expanding genetic codes for therapeutics, engineering biosynthetic pathways via genetic circuitry, and developing microbial systems for environmental bioremediation. Core technologies include deep learning for protein design, modular DNA assembly, and high-throughput selections. The lab also develops tools like MutCompute for enzyme engineering and domesticates non-model bacteria for bioproduction. His work emphasizes technology innovation, with recent advances in selenocysteine incorporation, L-DOPA sensing systems, and actinobacteria toolkits. The Thyer Lab actively collaborates on biocatalyst development and translational applications in healthcare and industry.
Prof. Dr. Soeren Lienkamp is an Assistant Professor at the Institute of Anatomy , Faculty of Medicine , University of Zurich . His work bridges digital education and genetic research , focusing on enhancing medical teaching through innovative formats. Research Interests : Genetics, developmental biology, kidney disease modeling, CRISPR applications, digital medical education, and advanced microscopy. Methodologies : Combines Xenopus tropicalis models, deep learning , and bioengineering to study genetic kidney disorders and improve diagnostic tools. Publication Trends : His recent articles highlight predictable genome editing , 3D imaging technologies , and mechanistic insights into kidney and eye development. Earlier works focus on ciliary function , Wnt signaling , and metabolic stress in renal cells.
Prof. Dr. med. Franz Lennard Ricklefs is a Senior Physician and Head of the Working Group at the Department of Neurosurgery, University of Hamburg Faculty of Medicine. He is a Medical Specialist in Neurosurgery with cross-disciplinary expertise in neuro-oncology, molecular pathology, and extracellular vesicle research. Affiliations: University Medical Center Hamburg-Eppendorf (UKE), European Liquid Biopsy Society (ELBS), International Consortium on Meningiomas (ICOM) Research Interests: His work focuses on neurosurgical oncology, particularly glioblastoma and meningioma pathobiology. He investigates DNA methylation patterns, extracellular vesicle biomarkers, and liquid biopsy implementation in clinical neuro-oncology. Additional interests include surgical outcomes for epilepsy and aneurysm management. Article Trends: Over the last decade, Dr. Ricklefs has published extensively on: Extracellular vesicle applications as liquid biopsy markers DNA methylation subclasses for glioblastoma and meningioma Multicenter surgical outcome benchmarking Immune evasion mechanisms in neuro-oncology Technological innovations in neurosurgical visualization Molecular characterization of rare CNS tumors Professional Contributions: He co-authored the MISEV2023 guidelines for extracellular vesicle studies and participates in international consensus reviews for meningioma classification. His collaborations span institutions across Europe and North America.
Philip Boone, MD, PhD, is an Attending Physician in the Division of Genetics and Genomics at Boston Children's Hospital and an Instructor of Pediatrics at Harvard Medical School. He specializes in medical genetics with particular expertise in rare disorders, medical mysteries, deletion and duplication syndromes, and Cornelia de Lange syndrome. Dr. Boone sees patients at Boston Children's Brookline location (2 Brookline Place, 7th Floor) and provides comprehensive genetic care including diagnostics, counseling, and individualized management. Stanford University (Undergraduate, 2006) Baylor College of Medicine (Graduate & Medical School, 2013-2014) Boston Combined Residency Program (Internship & Residency, 2016-2020) Harvard Medical School Genetics Training Program (Fellowship, 2020) Dr. Boone's research focuses on neurodevelopmental disorders, chromatin regulation, and genetic diagnostics. His work spans from fundamental genetic mechanisms to clinical applications, with particular emphasis on cohesinopathies including Cornelia de Lange syndrome. He has contributed significantly to understanding genetic variants associated with growth disorders, developmental features, and structural chromosomal abnormalities. His research combines advanced genomic technologies with clinical insights to improve diagnosis and management of rare genetic conditions. Analysis of Dr. Boone's publication record reveals a strong focus on medical genetics with emphasis on neurodevelopmental disorders, chromatin regulation, and genetic diagnostics. His work spans basic research on gene function and regulation to clinical applications in rare disease diagnosis. A notable trend is his investigation of cohesin complex disorders, particularly SMC3 variants and their relationship to Cornelia de Lange syndrome. His publications demonstrate expertise in both traditional genetic analysis and cutting-edge genomic technologies including long-read sequencing and telomere-to-telomere assembly. Dr. Boone actively contributes to medical education through publications on genetic diagnostics and distance learning resources for medical genetics. He has co-authored educational materials that help advance the field's knowledge base and training capabilities. As an attending physician in the Division of Genetics and Genomics at Boston Children's Hospital and a research fellow in the Center for Genomic Medicine at Massachusetts General Hospital, Dr. Boone works within one of the largest pediatric genetics practices in the country. The division includes over 30 board-certified clinical geneticists, genetic counselors, dieticians, and nursing staff who provide comprehensive care for patients with both common and extremely rare genetic conditions.
Xihong Lin is a Professor of Statistics at Harvard University and a Professor of Biostatistics at the Harvard T.H. Chan School of Public Health. She is a distinguished academic, holding membership in both the National Academy of Sciences and the National Academy of Medicine. Her research focuses on scalable statistical inference for big data, statistical machine learning, causal inference, and integrative data analysis, with applications in genomics, public health, and precision medicine. Lin’s work addresses challenges in analyzing large-scale genomic and multi-ancestry data, including methods for rare variant association testing, ancestry-adjusted sample analysis, and scalable computing frameworks. Her contributions span biobank studies (e.g., UK Biobank, TOPMed) and clinical applications in lung cancer, cardiovascular health, and smoking cessation. Her scientific awards reflect her leadership in statistical genetics and public health. Key research trends include leveraging single-cell sequencing for functional genomics, developing ensemble machine learning methods for health subtyping, and enhancing polygenic risk prediction across diverse populations. Lin’s methodologies prioritize interpretability and scalability, enabling impactful analyses of complex observational and genomic datasets. Awards: Member, National Academy of Sciences; Member, National Academy of Medicine Her grants and advising efforts focus on interdisciplinary collaborations, bridging statistics, AI, and domain sciences. Lin leads initiatives to improve genomic data management and ethical use of federated data (e.g., FADI framework). She is affiliated with labs advancing statistical genetics and cloud-based workflows (e.g., STAAR workflow).
Jossy Sayir is an Affiliated Lecturer and Senior Research Associate in the Department of Engineering at the University of Cambridge . Holding a Dipl. El.-Ing. ETH and Dr. Techn.-Wiss. from ETH Zurich, Sayir’s work bridges Information Theory and Bioinformatics , focusing on DNA-based data storage and error correction systems. They serve as Director of Studies in Engineering at Newnham College and coordinate Engineering Admissions. Interdisciplinary collaboration with the European Bioinformatics Institute Research on DNA data storage efficiency and cost reduction Expertise in channel coding, source coding, and 5G algorithms Teaching spans mathematics and information engineering modules in Part I Engineering Tripos, with Part II contributions on information theory, error control coding, and cryptography. Sayir also oversees data compression labs and serves as Wine Committee Chair, reflecting diverse interests in food, coffee, wine, music , and jazz . Best Lecturer Award, 2017-18 Research Fellowships in coding theory Key research trends include DNA storage encoding , LDPC decoders , polar code optimization , and Sudoku-inspired constraint coding . Sayir’s work addresses both theoretical and practical challenges in high-density data storage and next-generation communication protocols .
